Advertisement

Development and Limitations of Clinical Practice Guidelines

  • Bruce CulletonEmail author
Protocol
Part of the Methods in Molecular Biology™ book series (MIMB, volume 473)

Abstract

Clinical practice guidelines are systematically developed statements to assist practitioners and patients reach appropriate health care decisions. If developed properly, clinical practice guidelines assimilate and translate an abundance of evidence published on a daily basis into practice recommendations and, in doing so, reduce the use of unnecessary or harmful interventions and facilitate the treatment of patients to achieve maximum benefit and minimum risk at an acceptable cost. Traditionally, clinical practice guidelines were consensus-based statements, often riddled with expert opinion. It is now recognized that clinical practice guidelines should be developed according to a transparent process involving principles of bias minimization and systematic evidence retrieval and review, with a focus on patient-relevant outcomes. The process for the development, implementation, and evaluation of clinical practice guidelines are reviewed in this chapter.

Key words

Clinical practice guidelines clinical practice recommendations critical appraisal guideline grading implementation evaluation 

References

  1. 1.
    1.Hayward, R. S., Wilson, M. C., Tunis, S. R., Bass, E. B., Guyatt, G., The Evidence-Based Medicine Working Group. (1995) Users' guides to the medical literature, VIII. How to use clinical practice guidelines, A. Are the recommendations valid? JAMA 274, 570–574.PubMedCrossRefGoogle Scholar
  2. 2.
    National Health and Medical Research Council of Australia. (1999)A guide to the development, implementation, and evaluation of clinical practice guidelines. The National Health and Medical Research Council of Australia.Google Scholar
  3. 3.
    3.Browman, G. P. (2001) Development and aftercare of clinical guidelines: The balance between rigor and pragmatism. JAMA 286, 1509–1511.PubMedCrossRefGoogle Scholar
  4. 4.
    Global Programme on Evidence for Health Policy. (2003) Guidelines for WHO guidelines. World Health Organization, Geneva, Switzerland.Google Scholar
  5. 5.
    5.Guyatt, G., Vist, G., Falck-Ytter, Y., Kunz, R., Magrini, N., Schunemann, H. (2006) An emerging consensus on grading recommendations? Evid Based Med 11, 2–4.PubMedCrossRefGoogle Scholar
  6. 6.
    6.Uhlig K., Macleod A., Craig J., Lau J., Levey A. S., Levin A., Moist L., Steinberg E., Walker R., Wanner C., Lameire N., Eknoyan G. (2006) Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 70, 2058–2065.PubMedGoogle Scholar
  7. 7.
    7.Atkins, D., Best, D., Briss, P. A., Eccles, M., Falck-Ytter, Y., Flottorp, S., Guyatt, G. H., Harbour, R. T., Haugh, M. C., Henry, D., Hill, S., Jaeschke, R., Leng, G., Liberati, A., Magrini, N., Mason, J., Middleton, P., Mrukowicz, J., O'Connell, D., Oxman, A. D., Phillips, B., Schunemann, H. J., Edejer, T. T., Varonen, H., Vist, G. E., Williams, J. W., Jr., Zaza, S. (2004) Grading quality of evidence and strength of recommendations. BMJ 328, 1490.PubMedCrossRefGoogle Scholar
  8. 8.
    8.Choudhry, N. K., Stelfox, H. T., Detsky, A. S. (2002) Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 287, 612–617.PubMedCrossRefGoogle Scholar
  9. 9.
    9.Taylor, R., Giles, J. (2005) Cash interests taint drug advice. Nature 437, 1070–1071.PubMedCrossRefGoogle Scholar
  10. 10.
    Clinical practice guidelines and conflict of interest. (2005) CMAJ 173, 1297–1299.Google Scholar
  11. 11.
    11.Campbell, N., McAlister, F. A. (2006) Not all guidelines are created equal. CMAJ 174, 814–815.PubMedGoogle Scholar
  12. 12.
    12.Narins, R. G., Bennett, W. M. (2007) Patient care guidelines: Problems and solutions. Clin J Am Soc Nephrol 2, 1–2.PubMedCrossRefGoogle Scholar
  13. 13.
    13.Coyne D. W. (2007) Influence of industry on renal guideline development. Clin J Am Soc Nephrol 2, 3–7.PubMedCrossRefGoogle Scholar
  14. 14.
    14.Field, M. J., Lohr, K. N. (1992) Guidelines for Clinical Practice: From Development to Use. Institute of Medicine, National Academy Press, Washington, DC.Google Scholar
  15. 15.
    15.Shekelle, P. G., Ortiz, E., Rhodes, S., Morton, S. C., Eccles, M. P., Grimshaw, J. M., Woolf, S. H. (2001) Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: How quickly do guidelines become outdated? JAMA 286, 1461–1467.PubMedCrossRefGoogle Scholar
  16. 16.
    16.Zarnke, K. B., Campbell, N. R., McAlister, F. A., Levine, M. (2000) A novel process for updating recommendations for managing hypertension: Rationale and methods. Can J Cardiol 16, 1094–1102.PubMedGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Baxter-Renal DivisionMagaw ParkUSA

Personalised recommendations